Sepsis is caused by systemic distribution of microbial agents (in most
cases bacteria and fungi) and/or microbial products. It is characteri
zed by microcirculatory disturbances in several organs, followed by lo
ss of organ function. These may be caused by some direct >>toxic<< eff
icacy of microbial products (exotoxins, endotoxins), as well as indire
ctly via activation of a variety of mediator systems and inflammatory
competent cells (whole-body inflammation). This pathogenic sequence su
ggests therapeutic attempts to interfere with the systemic distributio
n of inflammatory mechanisms. High dose corticosteroids have shown no
benefit under these conditions in controlled clinical trials. This rev
iew summarises current approaches to suppress inflammatory mechanisms
in sepsis by blocking a variety of inflammatory mediators or inflammat
ory competent cells.